Neogen Corporation Reports 4% Revenue Drop in Q3

salesforce

NEOG|EPS $0.09|Rev $211.2M|Net Loss $17.0M
Stock $10.34

Mixed results. Neogen Corporation (NASDAQ: NEOG) delivered adjusted earnings of $0.09 per share in Q3 2026 when revenue of $211.2M declined 4.4% from the $221.0M recorded in the year-ago period. The company’s top line reflected industry headwinds despite stabilization in core business trends, with adjusted net income reaching $19.4M for the quarter. Q3 net loss, on a reported basis, was $17.0M.

Core stabilization emerging. While the year-over-year comparison remains challenged, the company’s core revenue growth of +0.1% signals an important inflection point after several quarters of pressure. The improvement suggests the business may be finding its footing after navigating difficult comps and market conditions. The near-flat core performance, while modest, represents genuine operational progress rather than financial engineering.

Food Safety resilient. The Food Safety segment demonstrated relative strength, generating $156.7M in revenue with 2.6% year-over-year growth. This performance is particularly noteworthy given the company’s overall 4.4% revenue decline, indicating that Food Safety is more than offsetting weakness elsewhere in the portfolio. As the company’s leading segment, this division’s ability to post positive growth provides a critical anchor for the broader business and suggests end-market demand in food testing and safety solutions remains healthy despite macro uncertainty.

Full-year guidance maintained. Management reaffirmed its full-year revenue expectations of $857.0M to $860.0M, a vote of confidence that the business can deliver an improvement in the fourth quarter. The unchanged guidance range suggests executives see the Q3 results as consistent with their internal expectations and view current trends as sustainable through year-end.

Analyst sentiment balanced. Wall Street’s current rating distribution of 4 Buy, 4 Hold, and zero Sell recommendations reflects a divided view on the stock’s near-term prospects. The absence of Sell ratings indicates analysts see downside as limited, but the even split between Buy and Hold suggests uncertainty about the timing and magnitude of a potential inflection.

What to Watch: The key question is whether Q3’s near-flat core revenue growth of +0.1% represents the bottom or merely a pause in the decline. Q4 execution will be critical in determining if Neogen can return to sustained positive growth, with particular focus on whether Food Safety’s momentum can accelerate and spread to other segments.

This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.

Newsdesk: